Category: business
-
UPI transactions hit record high of ₹29.9 lakh crore in May
National Payments Corporation of India (NPCI) said the value of transactions was at ₹29.03 lakh crore in April against ₹25.14 lakh crore in the same month a year ago, registering a 19% growth on an annual basis
-
North America, NE Asia, Latin America account for over 35% of India’s exports in FY26
Exports to East Africa increased 13.7% to $12.6 billion, accounting for 2.9% of India’s exports
-
Labour reforms: Government fully operationalises four new codes by publishing rules
The four labour codes were undertaken to address long-standing challenges and make the system more efficient and contemporary
-
Inflation expected to hit 4% in April as food and global risks rise: Bank of Baroda
Among the three kitchen staples—Tomato, Onion, and Potato (TOP)—the Consumer Price Index is expected to rise. Tomato, for instance, became 35.8% pricier in April 2026 compared to the same month last fiscal year.
-
Bombay High Court quashes FIR against HDFC Bank head in bribery case
The judges observed that the allegations did not meet the legal requirements for a criminal case
-
48% of NSE firms have no women as key managers; women losing out on higher paid jobs: study
Very few companies have more than two women on the Boards
-
48% of NSE firms have no women as key managers; women losing out on higher paid jobs: study
Very few companies have more than two women on the Boards
-
Core sector activity contracts 0.4% in March 2026 on West Asia impact, worst in 19 months
Data released by the government shows that four out of the eight core sectors of the economy contracted in March 2026; growth in the full year of 2025-26 was the lowest since the COVID-19 pandemic.
-
Reining in medicine prices despite war impact on pharma inputs: Official
Propylene remains the most critical input since it is used in Isopropyl Alcohol (IPA) and Isobutyl Benzene production, which are used in medicines such as Ibuprofen
-
Patented drug tariffs: India more or less shielded, says GTRI
U.S. President Trump signed an executive order, announcing the imposition of a 100% ad valorem duty on the import of certain patented pharmaceuticals and associated pharmaceutical ingredients